Vivos (RDGL) Interest Coverage Ratio Growth (3y) (2013 - 2021)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.80% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.94% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -35.05% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.28% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -4.98% |
| 10 | Vivos | - | - | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 20.66% |
| Sep 30, 2021 | -135.91% |
| Jun 30, 2021 | -1,502.38% |
| Mar 31, 2021 | -329.34% |
| Dec 31, 2020 | -410.60% |
| Sep 30, 2020 | -114.32% |
| Jun 30, 2020 | -68.90% |
| Mar 31, 2020 | 10.10% |
| Dec 31, 2019 | 372.12% |
| Sep 30, 2019 | 6.69% |
| Jun 30, 2019 | 7.60% |
| Mar 31, 2019 | -13.25% |
| Dec 31, 2018 | -270.16% |
| Sep 30, 2018 | -140.74% |
| Jun 30, 2018 | 59.13% |
| Mar 31, 2018 | 23.38% |
| Dec 31, 2017 | -2.61% |
| Sep 30, 2017 | -10.57% |
| Jun 30, 2017 | 14.32% |
| Mar 31, 2017 | 20.74% |
| Dec 31, 2016 | 26.45% |
| Sep 30, 2016 | -83.50% |
| Jun 30, 2016 | -41.25% |
| Mar 31, 2016 | -55.39% |
| Dec 31, 2015 | 25.52% |
| Sep 30, 2015 | 71.54% |
| Jun 30, 2015 | 47.48% |
| Mar 31, 2015 | 41.02% |
| Dec 31, 2014 | 64.59% |
| Sep 30, 2014 | 37.28% |
| Jun 30, 2014 | 38.99% |
| Mar 31, 2014 | 42.35% |
| Dec 31, 2013 | -6.46% |
| Sep 30, 2013 | -31.76% |
| Jun 30, 2013 | -50.59% |